148 related articles for article (PubMed ID: 15199483)
1. rFVIIai in Acute Coronary Syndromes.
Sorensen BB; Hedner U; Erhardtsen E
Semin Vasc Med; 2003 May; 3(2):199-204. PubMed ID: 15199483
[TBL] [Abstract][Full Text] [Related]
2. Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI.
Hedner U; Erhardtsen E
Ann Med; 2000 Dec; 32 Suppl 1():68-72. PubMed ID: 11209985
[TBL] [Abstract][Full Text] [Related]
3. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
4. Recombinant activated factor VII as a universal haemostatic agent.
Hedner U
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S147-52. PubMed ID: 9819047
[TBL] [Abstract][Full Text] [Related]
5. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
Del Turco S; De Caterina R
Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
[TBL] [Abstract][Full Text] [Related]
6. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.
Golino P; Ravera A; Ragni M; Cirillo P; Piro O; Chiariello M
Circulation; 2003 Dec; 108(23):2864-9. PubMed ID: 14656922
[TBL] [Abstract][Full Text] [Related]
7. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
Sørensen BB; Rao LV
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor and factor VIIa as therapeutic targets in disorders of hemostasis.
Hedner U; Ezban M
Annu Rev Med; 2008; 59():29-41. PubMed ID: 17845136
[TBL] [Abstract][Full Text] [Related]
9. Active site-inactivated factor VIIa prevents thrombosis without increased surgical bleeding: topical and intravenous administration in a rat model of deep arterial injury.
Söderström T; Hedner U; Arnljots B
J Vasc Surg; 2001 May; 33(5):1072-9. PubMed ID: 11331851
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor: structure, biology and involvement in disease.
Lwaleed BA; Bass PS
J Pathol; 2006 Feb; 208(3):327-39. PubMed ID: 16261634
[TBL] [Abstract][Full Text] [Related]
11. Relevance of tissue factor in cardiovascular disease.
Jude B; Zawadzki C; Susen S; Corseaux D
Arch Mal Coeur Vaiss; 2005 Jun; 98(6):667-71. PubMed ID: 16007822
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor in acute coronary syndromes.
Ott I
Semin Vasc Med; 2003 May; 3(2):185-92. PubMed ID: 15199481
[TBL] [Abstract][Full Text] [Related]
13. Targeting tissue factor as an antithrombotic strategy.
Golino P; Cimmino G
Semin Vasc Med; 2003 May; 3(2):205-14. PubMed ID: 15199484
[TBL] [Abstract][Full Text] [Related]
14. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
[TBL] [Abstract][Full Text] [Related]
15. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
16. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa.
Speidel CM; Thornton JD; Meng YY; Eisenberg PR; Edgington TS; Abendschein DR
Coron Artery Dis; 1996 Jan; 7(1):57-62. PubMed ID: 8773434
[TBL] [Abstract][Full Text] [Related]
17. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor pathway.
McVey JH
Baillieres Clin Haematol; 1994 Sep; 7(3):469-84. PubMed ID: 7841596
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model.
Suleymanov OD; Szalony JA; Salyers AK; LaChance RM; Parlow JJ; South MS; Wood RS; Nicholson NS
J Pharmacol Exp Ther; 2003 Sep; 306(3):1115-21. PubMed ID: 12829728
[TBL] [Abstract][Full Text] [Related]
20. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]